Ignite Creation Date:
2024-05-06 @ 9:16 AM
Last Modification Date:
2024-10-26 @ 12:12 PM
Study NCT ID:
NCT02948712
Status:
TERMINATED
Last Update Posted:
2022-06-30
First Post:
2016-10-27
Brief Title:
Adolescent and Young Adult Survivor Transition
Sponsor:
Case Comprehensive Cancer Center
Organization:
Case Comprehensive Cancer Center
Study Overview
Official Title:
Adolescent and Young Adult Survivor Transition AYAST
Status:
TERMINATED
Status Verified Date:
2022-06
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Slow Accrual
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
AYAST
Brief Summary:
The purpose of this study is to help adolescents and young adult cancer survivors address their psycho-social needs during the transitional period The transitional period begins at completion of cancer treatment and continues throughout that first year Patients often report this period can be difficult and distressing in many areas of life This study will use a simple tool to measure on a regular basis the level of distress a young adult may be feeling Based on this assessment additional mental health support and intervention can be recommended to help cancer survivors cope and enhance their feelings of well-being
Detailed Description:
Study Objective
To establish a successful distress based intervention program for adolescent and young adult survivors in the transition period
Study Design and Methods
The type of design for this study is a feasibility pilot study with repeated measure within group quantitative design There is no randomization for this study The patient will be assessed at baseline upon completion of therapy and at regular three month intervals for the first year for a total of five assessments After receiving a referral a member of the AYAST team will contact the patient and set up the initial visit
To establish a successful distress based intervention program for adolescent and young adult survivors in the transition period
Study Design and Methods
The type of design for this study is a feasibility pilot study with repeated measure within group quantitative design There is no randomization for this study The patient will be assessed at baseline upon completion of therapy and at regular three month intervals for the first year for a total of five assessments After receiving a referral a member of the AYAST team will contact the patient and set up the initial visit
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None